Search Results
Nov 07, 2025, 07:30 ET Soligenix Announces Recent Accomplishments and Third Quarter 2025 Financial Results
confirmatory Phase 3 study evaluating HyBryte™ (synthetic hypericin) in the treatment of cutaneous T-cell lymphoma (CTCL)," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. "Recently, we were pleased to announce that the first Data Monitoring Committee (DMC) meeting for
More news about: SOLIGENIX, INC.
Nov 07, 2025, 06:57 ET NYU Langone Cardiologists Share Leading Research at AHA Scientific Sessions 2025 & Dr. Judith S. Hochman Honored with Research Achievement Award
Chiara Giannarelli, MD, PhD, associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine
More news about: NYU Langone Health
Nov 06, 2025, 10:02 ET Universal "AI for Health" Summit Draws Health Leaders and Innovators for Two Days of Education to Help Shape the Future of Healthcare
Nawar Shara, PhD, founding co-director of the AI CoLab and chief of research data science for
More news about: MedStar Health
Nov 06, 2025, 09:30 ET Vector BioMed Expands LENTIVERSE™ Platform and Unveils New Brand Identity to Close the Gap Between CGT Innovation and Patient Access
"Vector BioMed spun out of Caring Cross to shift the conversation and relationship developers have with CDMOs," said Boro Dropulić, PhD MBA, Vector BioMed CEO, "Our new brand embodies our continued commitment to support all that are seeking a path to treat patients by various means. Our
More news about: Vector BioMed
Nov 06, 2025, 09:15 ET PhaseV Earns Three Prestigious Industry Awards Highlighting Leadership in AI for Clinical Development
leading pharmaceutical companies. "It's fantastic to see our team's dedication recognized with these honors," said Raviv Pryluk, PhD, CEO and Co-founder of PhaseV. "PhaseV is demonstrating the immediate, tangible value of AI in clinical development, moving beyond the hype to deliver
More news about: PhaseV
Nov 06, 2025, 08:30 ET Enhance Peptide Manufacturing Using Backbone N-Protecting Groups, Upcoming Webinar Hosted by Xtalks
PolyPeptide, Sweden; and Samuel J. Paravizzini, PhD Candidate, School of Chemistry, the University of Melbourne, for the live webinar on Tuesday, November 25, 2025, at 8am EST (2pm CET/EU-Central).
More news about: Xtalks
Nov 06, 2025, 08:07 ET Using Skin Biopsy Technology, CND Life Sciences Performs the 50,000th Syn-One Test® for Patients
healthcare teams." "It is not always easy to diagnose a neurological disorder quickly and definitely," said Kenneth M. Carnes, MD, PhD, a board-certified neurologist at Raleigh Neurology Associates in North Carolina. "When I see patients in my practice presenting with symptoms of a synucleinopathy,
More news about: CND Life Sciences
Nov 06, 2025, 08:00 ET One Third of Americans Have a Side Hustle, Collectively Earning $83.1B Extra per Month, Omnisend Survey Shows
it easy for brands of any size to sell more – all without the exaggerated cost. Email & SMS marketing shouldn't require a PhD. That's why 150,000 customers trust
More news about: Omnisend
Nov 06, 2025, 08:00 ET Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
efficiently, maintaining strong financial discipline as we prepare to enter the clinic and deliver potentially value-creating milestones," said Dave Lennon, PhD, President and CEO of Whitehawk Therapeutics. "I'm proud of our role in adding to the scientific understanding of PTK7 with the data we presented at
More news about: Whitehawk Therapeutics, Inc.
Nov 06, 2025, 08:00 ET Servier's New and Updated Data at 2025 ASH Annual Meeting Highlight Commitment to Hematology Research
portfolio, leaving no stone unturned as we endeavor to deliver innovative treatment options to as many eligible patients as possible, said Becky Martin, PhD, Chief of Medical, Servier Pharmaceuticals. "We're expanding our existing understanding of the clinical benefits of TIBSOVO to uncover its full potential
More news about: Servier Pharmaceuticals
Nov 06, 2025, 07:34 ET Cannformatics to Announce Dementia and Medical Cannabis Study at the 2nd Annual New York State Medical Cannabis Symposium
Itzhak Kurek, PhD, Co-founder and CEO of Cannformatics. "We are excited to collaborate with Northwell Health on this important study, which advances our mission to unlock
More news about: Cannformatics
Nov 06, 2025, 07:27 ET MavriX Bio Announces First Patient Dosed in ASCEND-AS Trial of MVX-220, Investigational Gene Therapy for Angelman Syndrome
urgency driving our work." "This trial represents a new era in Angelman syndrome research," said Dr. Elizabeth Berry-Kravis, MD, PhD, Professor of Pediatrics, Neurological Sciences, Anatomy and Cell Biology and Director of the RUSH Pediatric Neurosciences F.A.S.T Center for Translational
More news about: AS2Bio
Nov 06, 2025, 07:22 ET Eilean Therapeutics to Present First-in-Class, Wild-Type-Sparing JAK2-JH2/V617F Inhibitor ZE74-0282 at ASH 2025 and Initiate Clinical Studies in December 2025
durable disease modification. Contact: Amy Burd, PhD — Chief Scientific OfficerEilean Therapeutics LLCDover, DE, [email protected]
More news about: Eilean Therapeutics
Nov 06, 2025, 07:04 ET Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
phenotypes, offering a novel, disease-modifying small-molecule approach to obesity and T2D. Tudor Oprea, MD, PhD, Chief Executive Officer of Expert Systems Inc., highlighted the complementarity between the two companies' programs: "GPR75
More news about: Mwyngil Therapeutics
Nov 06, 2025, 07:00 ET NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board
biotechnology company advancing transformative therapies for neurodegenerative and metabolic diseases, today announced that Professor Tamir Ben-Hur, MD, PhD, a renowned neurologist and long-time scientific advisor of Kadimastem Ltd., will join the Company's Scientific Advisory Board.
More news about: NewcelX Ltd.
Nov 06, 2025, 04:33 ET QS Asia University Rankings 2026: KIIT Tops in Odisha
Asia University Rankings are based on criteria such as Citations per Paper, Papers per Faculty, Academic Reputation, Faculty Student Ratio, Staff with PhD, International Research Network, International Students, Outbound Exchange, International Faculty, and Employer Reputation. Expressing
More news about: KIIT
Nov 05, 2025, 21:31 ET Prevent Blindness Declares Sixth Annual Thyroid Eye Disease (TED) Week to Educate Public on Condition That Can Threaten Sight and Mental Wellness
TED Community Organization; Prem Subramanian, MD, PhD, Clifford R. and Janice N. Merrill Endowed Chair in Ophthalmology and Vice Chair for Academic Affairs at
More news about: Prevent Blindness
Nov 05, 2025, 14:48 ET The American Institute of Ultrasound in Medicine (AIUM) announces its 2026 Annual Convention, May 27-30 in Philadelphia
AIUM's annual conference to Philadelphia, home to the nation's first hospital and a birthplace of American medical innovation," said Steven R. Meyers, PhD, Chief Executive Officer of the AIUM. "Recognizing the value this event brings to the ultrasound community, the AIUM Board of Governors has enabled us
More news about: American Institute of Ultrasound in Medicine (AIUM)
Nov 05, 2025, 13:41 ET Drug Hunter, Inc. Announces the Appointment of Dr. Lori Friedman, Ph.D., to its Scientific Advisory Board
multimedia:https://www.prnewswire.com/news-releases/drug-hunter-inc-announces-the-appointment-of-dr-lori-friedman-phd-to-its-scientific-advisory-board-302605947.html
More news about: Drug Hunter
Nov 05, 2025, 12:15 ET HILL'S PET NUTRITION AND THE ASSOCIATION FOR ANIMAL WELFARE ADVANCEMENT ANNOUNCE 2025 WAGSIES AWARD WINNERS
understanding of their specific needs. As a leading veterinarian recommended pet food brand, knowledge is our first ingredient with nearly 200 veterinarians, PhD nutritionists and food scientists working to develop breakthrough innovations in pet health. Hill's Prescription Diet therapeutic nutrition plus our
More news about: Hill's Pet Nutrition
Nov 05, 2025, 10:57 ET Late-Breaking Clinical Trial Results Announced at VIVA 2025
Administration of Pentagalloylglucose: Clinical Evidence From a Phase I Study With the Nectero EAST® System Presented by: Ramon L. Varcoe, MBBS, PhD Study Design: Prospective, multicenter, OUS study of 46 patients with AAAs <5.5 cm in diameter. Patients were administered a one-time
More news about: The VIVA Foundation
Nov 05, 2025, 10:30 ET Children's Brain Tumor Network Names Dr. John Prensner as New Scientific Co-Chair
John Prensner, MD, PhD, as its new Scientific Co-Chair. A pediatric neuro-oncologist and physician-scientist at the Chad Carr Pediatric Brain Tumor Center at the
More news about: Children’s Brain Tumor Network
Nov 05, 2025, 09:00 ET Thryv Therapeutics to Present at the 2025 American Heart Association Scientific Sessions in New Orleans, LA
sodium/glucose cotransporter 2 inhibition Presenter: Saumya Das, MD, PhD, Co-Director, Resynchronization and Advanced Cardiac Therapeutics Program, Massachusetts General Hospital
More news about: Thryv Therapeutics Inc.
Nov 05, 2025, 08:30 ET Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting
author: PICI Investigator Ke Li, PhD (University of California, San Francisco)Co-authors: PICI Investigators David Y. Oh, MD, PhD (University of California, San Francisco); Alexander Marson, MD, PhD (Gladstone Institutes); Justin Eyquem, PhD (University of California, San
More news about: Parker Institute for Cancer Immunotherapy
Nov 05, 2025, 08:30 ET Engineering Peptide Stability Through Azapeptide Synthesis and Applications, Upcoming Webinar Hosted by Xtalks
Elizabeth Denton, PhD, Market Segment Manager, Biotage®; and Caroline Proulx, PhD, Associate Professor,
More news about: Xtalks